Matthew Vander Heiden
Physician-scientist and cancer metabolism expert who directs MIT's Koch Institute for Integrative Cancer Research.
Overview
Matthew Vander Heiden is Director of the Koch Institute for Integrative Cancer Research at MIT, with scientific, strategic and operational oversight of the institute. His laboratory studies how cell metabolism supports tumour growth, and he is a practising medical oncologist at Dana-Farber Cancer Institute. His 2009 Science review on the Warburg effect is one of the most cited papers in the field.
| Title | Journal | Year |
|---|---|---|
| Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation | Science | 2009 |
Pages like this
not linked directly; found by shared links- PersonRobert S. Langer
Shares David H. Koch Institute for Integrative Cancer Research at MIT and the tag clinician-scientist.
- PersonDiane M. Simeone
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonFrancisco Berrospi Espinoza
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonSenthil K. Muthuswamy
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonJürgen Weitz
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonOwen Sansom
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonRichard Schulick
Shares Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist.
- PersonTeresa Cotta-Dias
Shares Pancreatic ductal adenocarcinoma and the tag leadership.